[ 69 , 70 ] At the same time, sodium-glucose co-transporter 2 inhibitors, DPP-4 inhibitors, glucagon-like peptide-1 receptor agonists may not be significantly associated with VTE risk.
← all excerpts
Association between diabetes and venous thromboembolism: A systematic review and meta-analysis.
1
—
—